REGENXBIO Inc. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
REGENXBIO Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • REGENXBIO Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$56M, a 23.4% increase year-over-year.
  • REGENXBIO Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$249M, a 7.21% increase year-over-year.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2023 was -$268M, a 2% decline from 2022.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2022 was -$263M, a 264% decline from 2021.
  • REGENXBIO Inc. annual Operating Income (Loss) for 2021 was $160M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$268M -$5.25M -2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$263M -$423M -264% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $160M +$279M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$119M +$29.8M +20% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$149M -$237M -269% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $88.1M +$164M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$75.9M -$10.5M -16.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$65.3M -$42.2M -182% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$23.1M -$19.5M -528% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 -$3.68M +$1.09M +22.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
2013 -$4.78M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.